NEW YORK--(BUSINESS WIRE)--OMRIX Biopharmaceuticals, Inc. (“OMRIX” or the “Company”) (NASDAQ: OMRI), a fully-integrated biopharmaceutical company that develops and markets biosurgical and immunotherapy products, announced today that it will announce financial results for the first quarter ended March 31, 2008 before the opening of the U.S. financial markets on Friday, May 9, 2008. An accompanying conference call to discuss the results will be held the same day at 8:00 am ET; 5:00 a.m. PT.
